The challenge
A competitor vaccine manufacturer recently put a temporary hold on their vaccine development program, requiring Putnam’s client to update their global commercial forecast to account for a range of potential competitive launch scenarios. The forecast would be used to inform commercial strategy and supply chain decisions.
Our solution
Research objectives:
- Assess likelihood to recommend, stock vaccine across patient types and scenarios
- Quantify willingness to accept the vaccine based on variations in out-of-pocket cost and HCP recommendation
- Understand likelihood of protocol inclusion (LTC) and stocking likelihood (LTC + pharmacy)
Our approach:
We conducted four key research studies in US, EU5, and Japan:
- HCP Quantitative Demand Study
- Patient Quantitative Willingness to Pay Study
- Pharmacy Stakeholder Interviews
- Long-term Care Stakeholder Interviews
Both quantitative studies used a monadic design approach to test the impact of several competitive scenarios.
The results
Putnam delivered the findings and forecast inputs through a series of workshops with various client teams. This built alignment around the updated competitive landscape and helped team confidently make changes to their strategy.
Jump to a slide with the slide dots.
Patient Finding Through Data Tokenization
Refined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Read moreDigital share of voice and sentiment analysis at key congress
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Read moreData Strategy Development
Future-proofed data strategy with Putnam: gaps identified, vendors vetted, leading to a first US multi-source tokenized DB.
Read more